SALT LAKE CITY, April 24, 2025 (GLOBE NEWSWIRE) -- Clarus Corporation (NASDAQ: CLAR) (“Clarus” and/or the “Company”), a global company focused on the outdoor enthusiast markets, will hold a conference call on Thursday, May 8, 2025, at 5:00 pm ET to discuss its financial results for the first quarter ended March 31, 2025. The financial results will be reported in a press release after the close of regular stock market trading hours on the same day as the conference call. Date: Thursday, May 8, 2025Time: 5:00 ...

Core Viewpoint - Phillips Edison & Company, Inc. (PECO) reported strong financial results for Q1 2025, with net income of $26.3 million, or $0.21 per diluted share, reflecting a significant increase from the previous year [1][4]. Financial Results - Q1 2025 net income attributable to stockholders was $26.3 million, up from $17.7 million in Q1 2024 [4]. - Nareit FFO for Q1 2025 increased by 11.2% to $89.0 million, or $0.64 per diluted share, compared to $80.1 million, or $0.59 per diluted share in Q1 2024 [5]. - Core FFO for Q1 2025 also rose by 11.2% to $90.8 million, or $0.65 per diluted share, compared to $81.7 million, or $0.60 per diluted share in Q1 2024 [6]. Operational Highlights - Same-center NOI increased by 3.9% year-over-year to $115.1 million [8]. - The company reported a strong leased portfolio occupancy of 97.1% and same-center leased portfolio occupancy of 97.2% [7]. - Executed new leases at a rent spread of 28.1% and renewal leases at a rent spread of 20.8% during the quarter [7][11]. Portfolio Overview - As of March 31, 2025, PECO's portfolio consisted of 298 properties totaling approximately 33.5 million square feet across 31 states, an increase from 284 properties totaling 32.4 million square feet a year earlier [9]. - The company acquired six shopping centers for a total of $146.4 million and sold one for $24.9 million during the quarter [7][12]. Balance Sheet Highlights - As of March 31, 2025, PECO had approximately $760 million in total liquidity, including $7.9 million in cash and $751.8 million in borrowing capacity on its revolving credit facility [14]. - The company's net debt to annualized adjusted EBITDAre was 5.3x, compared to 5.0x at the end of 2024 [15]. 2025 Guidance - PECO affirmed its full-year 2025 earnings guidance, projecting Nareit FFO per share between $2.47 and $2.54, and Core FFO per share between $2.52 and $2.59 [18]. - The midpoint of full-year 2025 same-center NOI guidance represents a growth of 3.25% year-over-year [7].

Core Insights - Catheter Precision, Inc. is participating in the 46th annual Heart Rhythm Society (HRS) meeting from April 24 to 27, 2025, in San Diego, California, showcasing its advancements in cardiac electrophysiology [1][2] Company Overview - Catheter Precision is a U.S.-based medical device company focused on developing innovative solutions for the treatment of cardiac arrhythmias, particularly in electrophysiology procedures [8] Product Highlights - The company will feature four abstracts at HRS 2025, including three for its VIVO system and one for the LockeT device, indicating strong research validation and product resonance with the electrophysiology community [3][4] - VIVO is a non-invasive 3D imaging system that aids in identifying the origin of ventricular arrhythmias, streamlining workflow and reducing procedure time, and has received FDA marketing clearance and CE mark [6] - LockeT is a suture retention device designed for wound closure after percutaneous venous punctures, classified as a Class 1 device registered with the FDA [5] Research Findings - A multi-center study in Europe demonstrated that VIVO achieved over 94% accuracy in pre-procedure localization, with long-term procedural success exceeding 83% [7] - VIVO's efficacy in mapping and ablation for difficult-to-map premature ventricular contractions (PVCs) was highlighted in studies from two centers [7] - The safety and effectiveness of LockeT were confirmed in a study involving 139 patients, particularly for large-bore access electrophysiological procedures [7] - A novel study showed VIVO's accuracy in predicting exit site locations for scar-dependent ventricular tachycardia (VT), with an 89% prediction rate and an 86% correlation with successful ablation sites [7]

Core Insights - Merit Medical Systems, Inc. reported a revenue of $355.4 million for Q1 2025, reflecting a 9.8% increase compared to Q1 2024 [4][6] - The company achieved a constant currency revenue growth of 10.9% and an organic constant currency revenue increase of 6.0% year-over-year [4][6] - Non-GAAP earnings per share (EPS) rose by 14.8% to $0.86, while GAAP EPS increased by 2.0% to $0.49 [6][9] Financial Performance - The GAAP operating margin improved to 11.5% from 11.1% in the prior year, while the non-GAAP operating margin increased to 19.3% from 17.0% [6][8] - Free cash flow generation was reported at $19.5 million, down 20.5% compared to the previous year [6] - The company’s GAAP net income for Q1 2025 was $30.1 million, compared to $28.2 million in Q1 2024 [9] Revenue Breakdown - Revenue by segment showed significant growth in the Cardiovascular segment, with a 10.6% increase in Cardiac Intervention and a 20.5% increase in OEM [5] - The Endoscopy segment also saw substantial growth, with revenue increasing by 64.2% [7] - Total revenue for the Cardiovascular segment was $338.7 million, up 8.1% year-over-year [5] Guidance and Outlook - The company reaffirmed its total revenue guidance for 2025, projecting revenues between $1.470 billion and $1.490 billion, representing an 8% to 10% year-over-year increase [11] - Non-GAAP EPS guidance was updated to reflect stronger-than-expected Q1 results, now projected between $3.29 and $3.42 [11] - The company anticipates continued stable constant currency growth despite potential impacts from trade policies [5][11] Balance Sheet Highlights - As of March 31, 2025, Merit had cash and cash equivalents of $395.5 million, an increase from $376.7 million at the end of 2024 [10] - Total debt obligations remained stable at $747.5 million [10] - The company had an available borrowing capacity of approximately $697 million [10]

CHICAGO, April 24, 2025 (GLOBE NEWSWIRE) -- Century Aluminum Company (NASDAQ: CENX) will report first quarter 2025 earnings on Wednesday, May 7, 2025, after market close. The news release will be issued through GlobeNewswire. The company will hold a follow-up conference call on Wednesday, May 7, 2025, at 5:00 p.m. Eastern time. The earnings call will be webcast live on the Century Aluminum Company website, located at www.centuryaluminum.com. Plan to begin the registration process at least 10 minutes before ...

Core Viewpoint - RYVYL Inc. is negotiating to potentially restructure the terms of its pre-funded asset sale of its EU subsidiary, with a standstill period agreed until May 6, 2025, and a possible extension until May 27, 2025, contingent on a payment of $750,000 [1][2]. Group 1: Company Overview - RYVYL Inc. is a leading innovator in payment transaction solutions, focusing on electronic payment technology for international markets [3]. - The company was founded in 2017 as GreenBox POS and has developed a suite of financial products that emphasize security, data privacy, and rapid transaction settlement [3]. - RYVYL's platform can handle large volumes of immutable transactional records at high speeds, catering to various partners, merchants, and consumers globally [3]. Group 2: Financial Agreements - On January 24, 2025, RYVYL entered into a $15 million agreement structured as a pre-funded asset sale, with a 90-day closing period that could be terminated by a payment of $16.5 million before April 23, 2025 [2]. - The shares of the RYVYL EU subsidiary will remain in escrow during the ongoing standstill period [2].

REDWOOD CITY, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that it will report financial results for the first quarter 2025 on Tuesday, May 13, 2025. Company management will be webcasting a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the Investor section of Seer’s website at investor.seer.bio. An ar ...

SUNNYVALE, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that it will release financial results for the first quarter of 2025 after the close of trading on Thursday, May 8, 2025. Company management will host a conference call to discuss financial results beginning at 1:30 p.m. PT / 4:30 p.m. ET on May 8, 2025. Investors i ...

NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- Peloton Interactive, Inc. (NASDAQ: PTON) will release its third quarter 2025 financial results before the U.S. stock market opens on Thursday, May 8, 2025. The company will host a conference call and live audio webcast to discuss the financial results at 8:30 a.m. (Eastern Time) that day. This quarter, Peloton’s management will answer select questions from retail and institutional investors that are related to the company’s business updates and quarterly financia ...

CERRITOS, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- GEN Restaurant Group, Inc. (“GEN” or the “Company”) (Nasdaq: GENK), owner of GEN Korean BBQ, a fast-growing casual dining concept with an extensive menu and signature “grill at your table” experience, will hold a conference call on Tuesday, May 13, 2025, at 5:00 p.m. Eastern time to discuss its financial results for the first quarter ended March 31, 2025. The results will be reported in a press release prior to the conference call. Chairman and Chief Exec ...